Skip to content

Woebot

Woebot is an AI-powered chatbot that provides real-time, chat-based mental health support using evidence-based techniques like Cognitive Behavioral Therapy (CBT).

Freemium · API

Woebot in short

Get evidence-based mental health support 24/7 via chat, but it's an adjunct, not a replacement for human therapy.
stork0:00 / 0:04
Ava, one of 89 voices. Press play.
A voiceover costs 5 cents a minute.
Type up to 20,000 characters, get an MP3. 89 voices, 38 languages. Three free a day, a minute each.
Make a voiceover

What is Woebot?

Woebot is an AI-powered chatbot tool developed by Woebot Health that enables individuals seeking mental health support to receive real-time, chat-based mental health support. It utilizes evidence-based techniques like Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and Interpersonal Psychotherapy (IPT). Woebot engages users in text-based conversations, guiding them through therapeutic exercises, offering insights, and assisting in processing emotions and challenging negative thought patterns. It functions as a virtual coach, available 24/7, to build resilience and develop coping strategies for managing stress, anxiety, and depression.

Key Features of Woebot

Woebot Health provides a suite of features designed to deliver evidence-based mental health support through conversational AI, focusing on accessibility and clinical integration.

  • AI-powered chatbot for real-time, chat-based mental health support.
  • Utilizes Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and Interpersonal Psychotherapy (IPT) techniques.
  • API available for integration into third-party platforms and systems.
  • HIPAA aligned and SOC 2 Type 2 certified for data security and privacy.
  • Provides continuous emotional support and guidance.
  • Helps users develop and practice coping skills for various mental health challenges.
  • Supports individuals managing symptoms of depression and anxiety.
  • Offers programs and content addressing substance use.
  • Includes specialized content for adolescents, covering topics like media literacy and bullying.
  • Developed WB001, a digital therapeutic for postpartum depression, which received FDA Breakthrough Device Designation in 2021.

Who Should Use Woebot?

Woebot is designed for a diverse range of individuals and organizations seeking accessible, evidence-based mental health support and integration into existing healthcare frameworks.

  • Individuals seeking accessible, on-demand mental health support for managing symptoms of anxiety, depression, and stress.
  • Adolescents aged 13 to 17, with specialized content addressing topics such as media literacy, bullying, and body image.
  • Women experiencing postpartum depression, supported by the FDA Breakthrough Device Designated WB001.
  • Healthcare providers and organizations looking to integrate digital therapeutics into clinical workflows and extend continuity of care.
  • Patients seeking an adjunct to traditional therapy for consistent support and progress tracking between in-person appointments.

Woebot Pricing & Plans

Woebot Health has historically offered a freemium model for its direct-to-consumer application. However, a significant strategic pivot was announced, with the direct-to-consumer app scheduled for retirement on June 30, 2025. All user account data from the direct-to-consumer app will be anonymized after July 31, 2025. Woebot Health's current primary focus is on B2B partnerships, providing its AI-powered digital therapeutics to healthcare systems, employers, and other organizations through enterprise agreements. Specific pricing for these B2B solutions is determined via custom contracts.

  • Freemium Model: The direct-to-consumer Woebot app historically offered core features for free, with potential premium content or advanced features available through in-app purchases or subscriptions.
  • B2B Partnerships: Woebot Health primarily operates through partnerships with healthcare systems, employers, and organizations, with pricing structured via enterprise agreements and custom contracts.
  • Direct-to-Consumer App Retirement: The direct-to-consumer app will be retired on June 30, 2025, with all account data anonymized after July 31, 2025, marking a pivot to a B2B-focused model.

Woebot vs Competitors

Woebot Health positions itself with a strong B2B presence, emphasizing clinical validation through 14 Randomized Controlled Trials (RCTs) and integration into healthcare workflows. Its focus is on augmenting human care and providing scalable, evidence-based solutions for healthcare providers and enterprises.

Woebot

Freemium · API

From the Stork blog

Enjoying this? Get one like it in your inbox each morning.

one email a day · unsubscribe in two clicks · no third-party tracking